
Gliminus 1
Each tablet contains:
Glimepiride……………….. ……………………………………1 mg
Gliminus 2
Each tablet contains:
Glimepiride……………….. ……………………………………2 mg
Tablet
Glimepiride primarily lowers blood glucose by stimulating the release of insulin from pancreatic beta-cells. Sulphonylureas bind to the sulphonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin.
In healthy subjects, the time to reach maximal effect (minimum blood glucose concentrations) was approximately 2–3 hours after single oral doses of glimepiride. The effects of glimepiride on HbA1c, fasting plasma glucose, and post-prandial glucose have been assessed in clinical trials.
- Gliminus 1 – Strips of 10 Tablets
- Gliminus 2 – Strips of 10 Tablets

